SunLink Health Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
February 13, 2024 at 04:55 pm
Share
SunLink Health Systems, Inc. reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was USD 8.51 million compared to USD 10.64 million a year ago. Net loss was USD 3.08 million compared to net income of USD 1.95 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to basic earnings per share from continuing operations of USD 0.32 a year ago. Diluted loss per share from continuing operations was USD 0.06 compared to diluted earnings per share from continuing operations of USD 0.32 a year ago. Basic loss per share was USD 0.44 compared to basic earnings per share of USD 0.28 a year ago. Diluted loss per share was USD 0.44 compared to diluted earnings per share of USD 0.28 a year ago.
For the six months, sales was USD 17.07 million compared to USD 18.09 million a year ago. Net loss was USD 4.42 million compared to net income of USD 0.393 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to basic earnings per share from continuing operations of USD 0.24 a year ago. Diluted loss per share from continuing operations was USD 0.12 compared to diluted earnings per share from continuing operations of USD 0.24 a year ago. Basic loss per share was USD 0.63 compared to basic earnings per share of USD 0.06 a year ago. Diluted loss per share was USD 0.63 compared to diluted earnings per share of USD 0.06 a year ago.
SunLink Health Systems, Inc., through subsidiaries, owns businesses which provide healthcare products and services in certain markets in the southeastern United States. The Company operates through two segments: Healthcare Services and Pharmacy. The Healthcare Services segment subsidiaries owns and operates Trace Regional Medical Center (Trace), a 49-bed community hospital, clinics and a 66-bed nursing home in Mississippi, and an information technology (IT) service company based in Georgia. The Pharmacy segment subsidiary owns and operates a pharmacy business in Louisiana with four operational areas. The operational areas include retail pharmacy products and services provided to residents of southwestern Louisiana; institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products; non-institutional pharmacy services; and durable medical equipment (DME) consisting primarily of the sale and rental of products.